We are live on ! Find out more
LCM

Lynwood Capital Management Portfolio holdings

AUM $16.9M
1-Year Est. Return 19.31%
This Fund
S&P 500
This Quarter Est. Return
-6.08%
1 Year Est. Return
-19.31%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$89.5M
AUM Growth
-$3.64M
Cap. Flow
+$1.61M
Cap. Flow %
1.8%
Top 10 Hldgs %
34.74%
Holding
168
New
29
Increased
17
Reduced
34
Closed
24

Sector Composition

Rank Sector Weight
1 Financials 51.83%
2 Healthcare 9.88%
3 Technology 8.46%
4 Communication Services 8.06%
5 Materials 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TWNI
51
DELISTED
Tailwind International Acquisition Corp.
TWNI
$628K 0.7%
64,012
COCH icon
52
Envoy Medical
COCH
$54.3M
$621K 0.69%
63,396
DTRT
53
DELISTED
DTRT Health Acquisition Corp. Class A Common Stock
DTRT
$602K 0.67%
59,770
DTIL icon
54
Precision BioSciences
DTIL
$206M
$587K 0.66%
+12,223
New +$718K
GAPA
55
DELISTED
G&P Acquisition Corp.
GAPA
$583K 0.65%
58,647
+11,300
+24% +$112K
JUN
56
DELISTED
Juniper II Corp.
JUN
$571K 0.64%
57,546
TGVC
57
DELISTED
TG Venture Acquisition Corp. Class A Common Stock
TGVC
$549K 0.61%
55,362
+4,870
+10% +$48.4K
IBER
58
DELISTED
Ibere Pharmaceuticals
IBER
$504K 0.56%
51,400
SMAPU
59
DELISTED
SportsMap Tech Acquisition Corp. Units
SMAPU
$498K 0.56%
50,000
-23,999
-32% -$241K
FGMC
60
DELISTED
FG Merger Corp. Common Stock
FGMC
$498K 0.56%
+50,000
New +$498K
STET
61
DELISTED
ST Energy Transition I Ltd.
STET
$494K 0.55%
50,068
HAIA
62
DELISTED
Healthcare AI Acquisition Corp. Class A Ordinary Shares
HAIA
$412K 0.46%
41,493
+487
+1% +$4.85K
BLU
63
DELISTED
BELLUS Health Inc.
BLU
$362K 0.4%
39,211
-10,089
-20% -$82.5K
CERO
64
DELISTED
CERo Therapeutics
CERO
$347K 0.39%
17
+2
+13% +$40.1K
MACC
65
DELISTED
Mission Advancement Corp.
MACC
$342K 0.38%
35,000
IQMD
66
DELISTED
Intelligent Medicine Acquisition Corp. Class A Common Stock
IQMD
$315K 0.35%
31,454
MNTN
67
DELISTED
Everest Consolidator Acquisition Corporation
MNTN
$311K 0.35%
31,122
+972
+3% +$9.7K
ROCL
68
DELISTED
Roth CH Acquisition V Co. Common Stock
ROCL
$305K 0.34%
30,361
+5,000
+20% +$49.4K
BCSA
69
DELISTED
Blockchain Coinvestors Acquisition Corp. I Class A Ordinary Shares
BCSA
$298K 0.33%
30,042
LOKM
70
DELISTED
Live Oak Mobility Acquisition Corp.
LOKM
$294K 0.33%
30,000
+5,000
+20% +$49K
TVGN icon
71
Tevogen Inc. Common Stock
TVGN
$27M
$259K 0.29%
518
IVCB
72
DELISTED
Investcorp Europe Acquisition Corp I Class A Ordinary Shares
IVCB
$251K 0.28%
25,000
ACII
73
DELISTED
Atlas Crest Investment Corp. II
ACII
$251K 0.28%
25,600
SZZL
74
DELISTED
Sizzle Acquisition Corp. Common stock
SZZL
$250K 0.28%
25,001
LFAC
75
DELISTED
LF Capital Acquisition Corp. II Class A Common Stock
LFAC
$250K 0.28%
25,000

Similar funds

Lynwood Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Lynwood Capital Management held 168 positions worth $89.5M, down 3.9% from $93.2M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Lynwood Capital Management's Q2 2022 filing shows 29 new, 17 increased, 34 reduced and 24 closed positions. Its largest new stake was AT&T: 200,000 shares worth $4.19M. The largest sale was Altria Group, an estimated $2.61M.

By sector, the portfolio is most concentrated in Financials at 52% of assets, down from 52% a quarter earlier, followed by Healthcare and Technology.

  • Lynwood Capital Management's largest Q2 2022 buy was AT&T: 200,000 shares worth $4.19M.
  • Lynwood Capital Management added most to Americas Gold and Silver in Q2 2022, an estimated $467K increase.
  • Lynwood Capital Management's biggest Q2 2022 reduction was Briacell Therapeutics, cutting an estimated $889K.
  • Lynwood Capital Management fully exited Altria Group in Q2 2022, selling an estimated $2.61M.
  • Lynwood Capital Management's ten largest holdings make up 35% of its $89.5M portfolio in Q2 2022.
  • Lynwood Capital Management opened 29 new positions and closed 24 in Q2 2022.
  • Lynwood Capital Management's portfolio value fell 3.9% quarter-over-quarter to $89.5M.

Based on Lynwood Capital Management's 13F filing for Q2 2022, filed 2 Aug 2022.